Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril
versus a comparator in the treatment of patients with complicated skin and skin structure
infections. The study will also characterize the safety and tolerability of treatment with
ceftobiprole medocaril in patients with complicated skin and skin structure infections.